Recruiting
Phase 2

A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Code:

NCT04548648

Conditions

Central Nervous System Lymphoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Acalabrutinib

Isavuconazole

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information